Fulgent Genetics Income Statement (2015-2026) | FLGT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	153.62M	227.87M	251.67M	320.27M	125.34M	105.66M		66.17M	67.85M	84.69M	70.50M	64.48M	71.03M	71.74M	76.21M	73.46M	81.80M	84.07M	0.40M	71.14M
Cost of Revenue (Quarter)	5.22M	43.47M	8.20M	77.72M	10.87M	9.86M	10.25M	10.08M	47.28M	10.16M	45.28M	8.99M	44.54M	9.12M	-95.64M	45.12M	12.29M	48.56M	159.40M	49.65M
Gross Profit (Quarter)	117.76M	184.40M	189.54M	242.54M	65.28M	46.09M	12.99M	18.81M	20.57M	39.84M	25.23M	22.10M	26.49M	26.77M	31.85M	28.35M	34.44M	35.51M	32.58M	21.49M
Operating items
Amortization - Intangibles (Quarter)		0.80M	0.91M	0.91M	1.57M	2.01M	2.01M	1.97M	1.96M	1.96M	1.91M	2.00M	2.00M	1.99M	1.97M	2.00M	2.00M	2.00M	2.03M	2.00M
Research & Development (Quarter)	5.31M	6.02M	7.46M	5.99M	6.91M	7.51M	8.51M	9.78M	9.69M	10.01M	11.95M	11.43M	13.49M	11.78M	12.11M	12.39M	13.48M	13.86M	14.17M	14.18M
Selling, General & Administrative (Quarter)	8.33M	12.30M	22.10M	25.77M	30.24M	26.27M	28.79M	21.80M	17.99M	17.50M	31.71M	21.49M	21.33M	20.95M	24.34M	25.29M	26.39M	23.34M	41.65M	27.68M
Restructuring Costs (Quarter)																		0.10M	1.50M	0.40M
Other Operating Expenses (Quarter)	83.27M	121.05M	89.68M	8.85M	10.46M	1.89M	-23.83M	12.05M	12.69M	12.12M	132.69M	10.98M	10.59M	-14.44M	11.53M	-13.69M	14.28M	-6.50M	11.50M	-24.51M
Operating Expenses (Quarter)	18.86M	25.13M	38.68M	40.61M	52.48M	45.74M	49.54M	43.63M	40.37M	39.63M	176.35M	43.90M	45.40M	43.85M	47.98M	48.14M	54.15M	50.86M	68.82M	56.11M
Operating Income (Quarter)	98.90M	159.27M	150.86M	201.93M	12.79M	0.35M	0.80M	-24.82M	-19.80M	0.21M	-151.12M	-21.80M	-18.91M	-17.08M	-16.14M	-19.80M	-19.71M	-15.35M	-0.50M	-34.62M
EBIT (Quarter)	98.90M	159.27M	150.86M	201.93M	12.79M	0.35M	0.80M	-24.82M	-19.80M	0.21M	-151.12M	-21.80M	-18.91M	-17.08M	-16.14M	-19.80M	-19.71M	-15.35M	-0.50M	-34.62M
Non-operating items
Interest & Investment Income (Quarter)	0.60M	0.50M	-0.04M	0.04M	0.96M	1.41M	3.22M	3.77M	5.10M	6.47M	5.81M	7.38M	7.71M	8.09M	8.12M	8.02M	8.09M	7.87M	6.94M	8.65M
Other Non Operating Income (Quarter)										0.24M	-0.02M	-0.01M	0.01M	0.54M	0.01M	0.07M	0.05M	-0.01M	0.04M	0.01M
Non Operating Income (Quarter)										6.65M	21.10M	-0.01M	7.69M	-1.45M	-13.31M	0.07M	0.05M	-0.01M	-13.95M	8.64M
Net income details
EBT (Quarter)	99.50M	159.77M	150.82M	201.98M	13.75M	1.76M	-33.46M	-21.05M	-14.70M	6.86M	2.27M	-14.17M	-11.21M	-18.53M	-2.90M	-11.72M	-21.52M	-7.51M	32.48M	-25.98M
Tax Provisions (Quarter)	23.59M	37.55M	47.15M	48.42M	2.65M	0.41M	-9.39M	-5.20M	-3.10M	20.30M	-22.31M	-0.33M	-2.12M	-3.84M	-1.85M	0.20M	-2.30M	-0.70M	-4.49M	-0.70M
Profit After Tax (Quarter)	79.81M	122.52M	104.34M	153.56M	11.10M	1.72M	-24.08M	-15.85M	-11.59M	-13.11M	-134.33M	-13.85M	-9.09M	-14.65M	-6.19M	-11.90M	-19.26M	-6.83M	-23.42M	-24.83M
Equity Income (Quarter)
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)	-0.17M	-0.30M	-0.66M	-0.42M	-0.44M	-0.38M	-0.24M	-0.51M	-0.36M	-0.36M	-6.18M	-0.38M	-0.38M	-0.05M	-0.30M	-0.37M	-0.30M	-0.22M	-0.23M	-0.45M
Income from Continuing Operations (Quarter)	75.91M	122.22M	103.68M	153.56M	11.10M	1.34M	-24.08M	-15.85M	-11.60M	-13.44M	24.58M	-13.85M	-9.09M	-14.69M	-1.05M	-11.92M	-19.22M	-6.81M	36.98M	-25.28M
Consolidated Net Income (Quarter)	75.91M	122.22M	103.68M	153.56M	11.10M	1.34M	-24.08M	-15.85M	-11.60M	-13.44M	24.58M	-13.85M	-9.09M	-14.69M	-1.05M	-11.92M	-19.22M	-6.81M	36.98M	-25.28M
Income towards Parent Company (Quarter)	75.91M	122.22M	103.68M	153.56M	11.10M	1.34M	-24.08M	-15.85M	-11.60M	-13.44M	24.58M	-13.85M	-9.09M	-14.69M	-1.05M	-11.92M	-19.22M	-6.81M	36.98M	-25.28M
Net Income towards Common Stockholders (Quarter)	75.91M	122.22M	103.68M	153.56M	11.10M	1.34M	-24.08M	-15.34M	-11.23M	-13.11M	-128.15M	-13.46M	-8.71M	-14.65M	-5.89M	-11.53M	-18.96M	-6.61M	-23.42M	-24.83M
Additional items
EPS (Basic) (Quarter)	2.74	4.13	3.48	5.09	0.38	0.06	-0.80	-0.52	-0.38	-0.44	-4.30	-0.45	-0.29	-0.48	-0.19	-0.37	-0.62	-0.21	-0.76	-0.80
EPS (Weighted Average and Diluted) (Quarter)	2.59	3.93	3.34	4.93	0.37	0.06	-0.80	-0.52	-0.38	-0.44	-4.30	-0.45	-0.29	-0.48	-0.19	-0.37	-0.62	-0.21	-0.76	-0.80
Shares Outstanding (Weighted Average) (Quarter)	28.99M	29.22M	29.41M	30.23M	30.36M	30.17M	30.10M	29.54M	29.81M	30.01M	29.78M	29.77M	29.93M	30.42M	30.23M	30.83M	30.69M	30.71M	30.78M	30.88M
Shares Outstanding (Diluted Average) (Quarter)	30.81M	30.91M	30.98M	31.24M	31.19M	31.11M	30.96M	29.54M	29.81M	30.01M		29.77M	30.10M	30.09M		30.83M	30.54M	30.71M		30.88M
EBITDA (Quarter)	98.90M	159.27M	150.86M	201.93M	12.79M	0.35M	0.80M	-24.82M	-19.80M	0.21M	-151.12M	-21.80M	-18.91M	-17.08M	-16.14M	-19.80M	-19.71M	-15.35M	-0.50M	-34.62M
Interest Expenses (Quarter)										0.07M	-0.14M	-0.25M	0.03M	0.01M	0.04M	0.01M	0.02M	0.03M	0.02M	0.02M
Tax Rate (Quarter)	23.71%	23.50%	31.26%	23.97%	19.29%	23.56%	28.05%	24.70%	21.09%	295.92%	-983.77%	2.31%	18.94%	20.71%	63.92%	-1.71%	10.69%	9.32%	-13.82%	2.69%

Research Tools

Fulgent Genetics Income Statement (2015-2026) | FLGT

Create an account

Sign In

Reset Password